Bicalutamide 50 MG Oral Tablet [Casodex] — RxCUI 108828
RxNorm drug concept · Semantic branded drug
RxCUI 108828
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI108828
Official nameBicalutamide 50 MG Oral Tablet [Casodex]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asCasodex 50 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Bicalutamide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's used along with an LHRH analog, another hormone therapy, to treat prostate cancer that has spread (Stage D2 metastatic). It blocks male hormones from fueling the cancer. It is...
- Take one tablet by mouth once a day, morning or evening, with or without food. Try to take it at the same time each day and start it with your LHRH analog. If you miss a dose, just...
- Hot flashes are the most common. Some people also have pain, tiredness, constipation, nausea, diarrhea, swelling, or blood in the urine. Tell your doctor if any of these bother you...
- Bicalutamide can rarely cause serious liver injury, usually in the first few months. Testing before you start, regularly for four months, and then periodically helps catch problems...
🕸️ Concept Web — How Bicalutamide 50 MG Oral Tablet [Casodex] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Bicalutamide 50 MG Oral Tablet [Casodex]
RxCUI 108828 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Bicalutamide
83008IN
-
Bicalutamide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Casodex
151495BN
-
Casodex
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Bicalutamide Oral Tablet
371070SCDF -
Bicalutamide Oral Product
1161189SCDG -
Bicalutamide Pill
1161190SCDG -
Bicalutamide Oral Tablet [Casodex]
369055SBDF -
Casodex Oral Product
1175807SBDG -
Casodex Pill
1175808SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Bicalutamide Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Bicalutamide 50 MG Oral Tablet
199123SCD -
Bicalutamide 50 MG
315478SCDC -
Bicalutamide 50 MG [Casodex]
564608SBDC
-
Bicalutamide 50 MG Oral Tablet
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Bicalutamide 50 MG Oral Tablet
SCD · 199123 -
Bicalutamide 50 MG
SCDC · 315478 -
Bicalutamide Oral Tablet
SCDF · 371070 -
Bicalutamide Oral Product
SCDG · 1161189 -
Bicalutamide Pill
SCDG · 1161190
Brand-Name Concepts
-
Bicalutamide 50 MG [Casodex]
SBDC · 564608 -
Bicalutamide Oral Tablet [Casodex]
SBDF · 369055 -
Casodex Oral Product
SBDG · 1175807 -
Casodex Pill
SBDG · 1175808 -
Casodex
BN · 151495
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 108828 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 62559-0680-30 | 30 TABLET in 1 BOTTLE (62559-680-30) | CASODEX | ANI Pharmaceuticals, Inc. | 2018-06-26 |
Observed labelers:
ANI Pharmaceuticals, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.